Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NQO2 | P16083 | 2/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2314445 | 0.76 | MAPT (0.35) | CYP2A6ALDH1A1GLAMAPTHPGD | |
| SCHEMBL456729 | 0.74 | CYP2A6 (0.46) | CYP2A6ALDH1A1GLAMAPTHPGD | |
| SCHEMBL7300296 | 0.74 | ALDH1A1 (0.30) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL3952850 | 0.73 | CYP1A2 (0.44) | CYP2A6ALDH1A1GLAMAPTHPGD | |
| SCHEMBL457801 | 0.73 | CYP2A6 (0.44) | CYP2A6ALDH1A1GLAMAPTHPGD | |
| SCHEMBL5999904 | 0.73 | ALDH1A1 (0.32) | CYP2A6ALDH1A1GLAMAPTHPGD | |
| SCHEMBL75079 | 0.73 | ALDH1A1 (0.44) | CYP2A6ALDH1A1GLAMAPTHPGD | |
| SCHEMBL458019 | 0.73 | CYP2A6 (0.44) | CYP2A6ALDH1A1GLAMAPTHPGD | |
| SCHEMBL9720823 | 0.73 | CYP2A6 (0.44) | CYP2A6ALDH1A1GLAMAPTHPGD | |
| SCHEMBL455449 | 0.73 | ALDH1A1 (0.32) | CYP2A6ALDH1A1GLAMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101287472-B | Antiviral 4'-substituted pre-nucleotide phosphoramidates | HOFFMANN LA ROCHE | 2011-10-12 | — | — | CN | claimed |
| CN-101287472-A | Antiviral 4'-substituted pre-nucleotide phosphoramidates | ROCHE PALO ALTO LLC (CH) | 2008-10-15 | — | — | CN | claimed |
| EP-1928475-A2 | ANTIVIRAL PHOSPHORAMIDATES OF 4'-SUBSTITUTED PRONUCLEOTIDES | F.HOFFMANN-LA ROCHE AG (CH) | 2008-06-11 | — | — | EP | claimed |
| WO-2007020193-A2 | ANTIVIRAL PHOSPHORAMIDATES OF 4 ' -SUBSTITUTED PRONUCLEOTIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2007-02-22 | — | — | WO | claimed |
| WO-2020246329-A1 | METHOD FOR PRODUCING β-KETOSULFONE COMPOUND | 住友化学株式会社 | 2020-12-10 | — | — | WO | disclosed |
| EP-2841429-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL CO (JP) | 2020-10-21 | — | — | EP | disclosed |
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| EP-3045450-B1 | INTERMEDIATE COMPOUNDS IN PROCESSES FOR PRODUCING PYRIDAZINONE COMPOUNDS | SUMITOMO CHEMICAL CO (JP) | 2018-02-07 | — | — | EP | disclosed |
| EP-2841433-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE | SUMITOMO CHEMICAL CO (JP) | 2017-06-21 | — | — | EP | disclosed |
| US-9565856-B2 | Tetrazolinone compounds and its use as pesticides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-14 | — | — | US | disclosed |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
| EP-3045450-A1 | INTERMEDIATE COMPOUNDS IN A PROCESS FOR PRODUCING PYRIDAZINONE COMPOUNDS | SUMITOMO CHEMICAL CO., LTD. (JP) | 2016-07-20 | — | — | EP | disclosed |
| US-4481369-A | VIA TRICARBONYL(TRIPHENYLPOSPHINE) COBALTATE | ETHYL CORPORATION (US) | 1984-11-06 | — | — | US | disclosed |
| US-4082517-A | CYCLOPENTADIENYL MANGANESE ANTIKNOCK | ETHYL CORPORATION (US) | 1978-04-04 | — | — | US | disclosed |
| US-RE29488-E | CYCLOPENTADIENYL MANGANESE TRICARBONYL, CARBOXYMETHOXY-SUCCINIC ACIDS | ETHYL CORPORATION (US) | 1977-12-06 | — | — | US | disclosed |
| US-4052171-A | FUEL COMPOSITIONS AND ADDITIVE MIXTURES CONTAINING METHANETRICARBOXYLATES FOR REDUCING EXHAUST GAS CATALYST PLUGGING | ETHYL CORPORATION (US) | 1977-10-04 | — | — | US | disclosed |
| US-4005993-A | CYCLOPENTADIENYL MANGANESE TRICARBONYL, OXYALKYL-MALONIC ACIDS OR ESTERS | ETHYL CORPORATION (US) | 1977-02-01 | — | — | US | disclosed |
| US-4005992-A | CYCLOPENTADIENYL MAGNESIUM TRICARBONYL, OXYMETHYLENEMALONIC ACIDS OR ESTERS | ETHYL CORPORATION (US) | 1977-02-01 | — | — | US | disclosed |
| US-3958955-A | CYCLOPENTADIENYL MANGANESE TRICARBONYL ANTIKNOCK | ETHYL CORPORATION (US) | 1976-05-25 | — | — | US | disclosed |
| US-3950145-A | ANTIKNOCK | ETHYL CORPORATION (US) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | CBR1, HAO2, CBR3 | CYP2A6 375/4885ALDH1A1 151/4885GLA 886/4885 |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | CBR1, HAO2, CBR3 | CYP2A6 375/4885ALDH1A1 151/4885GLA 886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.